In conclusion, Akebia Therapeutics Inc. (AKBA) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold” ...
Some results have been hidden because they may be inaccessible to you